Topic

Hemgenix (etranacogene dezaparvovec)

A collection of 33 issues

Renewing Hemgenix (etranacogene dezaparvovec) Approval with Blue Cross Blue Shield in Pennsylvania: Annual Requirements and Timeline

Answer Box: Renewing Hemgenix Coverage in Pennsylvania Hemgenix (etranacogene dezaparvovec) is a one-time gene therapy, but Blue Cross Blue Shield plans in Pennsylvania may require annual clinical documentation for outcomes monitoring and related services coverage. Start renewal submissions 60-90 days before your authorization period expires. Submit updated Factor IX levels,
7 min read

How to Get Hemgenix (Etranacogene Dezaparvovec) Covered by Humana in North Carolina: Prior Authorization Guide and Appeals Process

Answer Box: Getting Hemgenix Covered by Humana in North Carolina Hemgenix (etranacogene dezaparvovec) requires prior authorization from Humana for adults with moderate to severe hemophilia B. The fastest path to approval involves three key steps: (1) Have your hematologist submit a comprehensive PA request with Factor IX levels ≤2%, bleeding
5 min read

How to Get Hemgenix (etranacogene dezaparvovec) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Hemgenix Covered by Aetna CVS Health in Florida Fastest path to approval: Submit prior authorization with Factor IX activity ≤2%, negative inhibitor test, documented prophylaxis failure (≥150 exposure days), and hematologist attestation. First step today: Contact your hemophilia treatment center to begin gathering required labs and treatment
5 min read

Getting Hemgenix (etranacogene dezaparvovec) Approved by UnitedHealthcare in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: How to Get Hemgenix Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Hemgenix (etranacogene dezaparvovec) with strict clinical criteria: 50+ Factor IX exposure days, no inhibitors, adult status, and normal liver function. Step 1: Submit PA through the UnitedHealthcare Provider Portal with comprehensive documentation from a
5 min read

Getting Hemgenix (Etranacogene Dezaparvovec) Covered by Humana in Illinois: Complete Prior Authorization Guide with ICD-10 Codes and Appeal Steps

Answer Box: Getting Hemgenix Covered by Humana in Illinois Hemgenix (etranacogene dezaparvovec) requires prior authorization from Humana Medicare Advantage in Illinois. You'll need ICD-10 code D67 (hereditary factor IX deficiency), documentation of severe hemophilia B with ≤2% factor IX activity, and treatment at a CSL Behring-approved center of
6 min read